News - Headlands Research

About
Our Sites
CROs & Sponsors
Information Hub
- Blog
- Events
- In the Media
- News
- Resources
Careers
Contact

About
Our Sites
CROs & Sponsors
Information Hub
- Blog
- Events
- In the Media
- News
- Resources
Careers
Contact

News

June 28, 2023

June 28, 2023

Headlands Research Appoints Kyle Burtnett as Chief Executive Officer

Read More

May 18, 2023

Laura Teschner

May 18, 2023

Laura Teschner Joins Headlands Research as Chief People Officer

Read More

May 4, 2023

May 4, 2023

Headlands Research Acquires Clinvest Research — the Clinical Research Site Network’s Third Addition of 2023

Read More

April 18, 2023

April 18, 2023

Headlands Research Acquires Established Eastern Massachusetts–Based Research Site Specializing in Neurodegenerative Diseases

Read More

March 23, 2023

Headlands Research Detroit

March 23, 2023

Headlands Research Deepens Diversity and Expands Network with Launch of Metro Detroit–Based Clinical Trial Site

Read More

December 5, 2022

December 5, 2022

Lecanemab Represents Promising Therapy for Alzheimer Disease

Read More

December 1, 2022

December 1, 2022

Dr. Sharon Cohen Discusses Alzheimer’s in Canada on the Social CTV

Read More

November 10, 2022

November 10, 2022

Headlands Research CEO Mark Blumling Joins SCRS Talks to Discuss Collaborating for Site Sustainability: The Ins & Outs of Site Networks

Read More

November 3, 2022

November 3, 2022

First Patient Dosed in Clairvoyant’s Phase 2 Clinical Trial Exploring Psilocybin as a Treatment for Alcohol Use Disorder

Read More

June 30, 2022

June 30, 2022

Headlands Research Further Expands its Leading Clinical Research Site Network by Acquiring Peninsula Research Associates

Read More

Posts pagination

← 1 2 3 … 5 →

130 John F Kennedy Dr STE 203 Lake Worth, FL 33462

© 2024 Headlands Research. | Privacy Policy

Facebook
LinkedIn
Twitter